Abstract
Mycobacterium abscessus is the fast-growing mycobacteria (MCR) specie that most cause lung and extrapulmonary infections. This microorganism has the ability to persist in hospital settings and is one of the most resistant species. The drug clarithromycin is the basis of combined therapy against M. abscessus infections, However, therapeutic response is associated with mechanisms of induced…